Generic industry boss: SPC manufacturing waiver won't harm originators' innovation

Stimulating Investment in European Generic, Biosimilar and… 22 March 2017 Key authorities, eminent lawyers and industry leaders discussed today in…
EU-Canada Free Trade Agreement: an Opportunity to Create… 20 February 2017 Medicines for Europe welcomes the approval by the European Parliament…
The European Parliament Calls on the Commission to Boost… 21 April 2016 Launched on 28 October 2015 , the European Commission’s new…
Commission sponsored study shows Supplementary Protection… 18 October 2017 On Thursday 12 October, the Directorate-general for Internal Market, Industry,…

Generic industry boss: SPC manufacturing waiver won’t harm originators’ innovation